(43) reported that STAT3 silencing sensitizes nilotinib-resistant CML cells by switching their energy metabolism from glycolysis to mitochondrial respiration. The gene discussed is STAT3; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.